Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.36 |
| ▸ | CCR1 | P32246 | 2/20 | 0.35 |
| ▸ | CCR5 | P51681 | 1/20 | 0.35 |
| ▸ | CCR8 | P51685 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | UNG | P13051 | 1/20 | 0.33 |
| ▸ | FDPS | P14324 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29163627 | 0.85 | ALDH1A1 (0.35) | ALDH1A1CCR1CCR5CCR8TSHR | |
| SCHEMBL30786154 | 0.85 | ALDH1A1 (0.34) | ALDH1A1KDM4EPTGS2RAB9ACYP2A6 | |
| SCHEMBL3465730 | 0.78 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL9347247 | 0.78 | KDM4E (0.56) | ALDH1A1KDM4ERAB9ACYP2A6LMNA | |
| SCHEMBL7609085 | 0.78 | ERN1 (0.38) | ALDH1A1KDM4ERAB9ACCR1CCR5 | |
| SCHEMBL29387096 | 0.78 | CCR1 (0.42) | ALDH1A1KDM4EPTGS2RAB9ACYP2A6 | |
| SCHEMBL730405 | 0.78 | CCR1 (0.42) | ALDH1A1KDM4EPTGS2RAB9ACYP2A6 | |
| SCHEMBL30259554 | 0.76 | CCR1 (0.41) | ALDH1A1KDM4EPTGS2RAB9ACYP2A6 | |
| SCHEMBL30259309 | 0.76 | CCR1 (0.41) | ALDH1A1KDM4EPTGS2RAB9ACYP2A6 | |
| SCHEMBL24766044 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114874722-B | Moisture-heat-resistant epoxy conductive adhesive, preparation method and application thereof | 东莞市德聚胶接技术有限公司 | 2023-01-10 | — | — | CN | claimed |
| CN-114874722-A | Moisture-heat-resistant epoxy conductive adhesive, preparation method and application thereof | 东莞市德聚胶接技术有限公司 | 2022-08-09 | — | — | CN | claimed |
| EP-3303308-B1 | SEPARATION OF ENANTIOMERS OF 3-ETHYLBICYCLO[3.2.0]HEPT-3-EN-6-ONE | NOVASSAY SA (CH) | 2019-10-09 | — | — | EP | claimed |
| US-10150723-B2 | Separation of enantiomers of 3-ethylbicyclo[3.2.0]hept-3-en-6-one | NOVASSAY S.A. (CH) | 2018-12-11 | — | — | US | claimed |
| US-20180134643-A1 | SEPARATION OF ENANTIOMERS OF 3-ETHYLBICYCLO[3.2.0]HEPT-3-EN-6-ONE | NOVASSAY S.A. (CH) | 2018-05-17 | — | — | US | claimed |
| EP-3303308-A1 | SEPARATION OF ENANTIOMERS OF 3-ETHYLBICYCLO[3.2.0]HEPT-3-EN-6-ONE | Novassay SA (CH) | 2018-04-11 | — | — | EP | claimed |
| CN-106434754-A | Composite containing anti-PD-1 gene and polycation and its application in treating cancer | 上海云舜生物技术有限公司 | 2017-02-22 | — | — | CN | claimed |
| CN-106399380-A | Compound containing anti-PD (Program Death)-1 gene and poly-spermidine and application of compound to treatment of tumors | 上海云舜生物技术有限公司 | 2017-02-15 | — | — | CN | claimed |
| WO-2016146299-A1 | SEPARATION OF ENANTIOMERS OF 3-ETHYLBICYCLO[3.2.0]HEPT-3-EN-6-ONE | NOVASSAY SA (CH) | 2016-09-22 | — | — | WO | claimed |
| CN-104353085-A | Poly spermine polymer-contained nano-particle, and preparation method and application thereof | UNIV SHANGHAI JIAOTONG | 2015-02-18 | — | — | CN | claimed |
| CN-104324387-A | BDNF gene-PEI derivative nano-particle composition, preparation method and application thereof | XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG U | 2015-02-04 | — | — | CN | claimed |
| CN-104288783-A | Polycation nanoparticle for treating aplastic bone marrow as well as preparation method and application thereof | UNIV SHANGHAI JIAOTONG | 2015-01-21 | — | — | CN | claimed |
| CN-104258417-A | GDNF gene-PEI derivative nano-particle compound as well as preparation method and application thereof | XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG U | 2015-01-07 | — | — | CN | claimed |
| CN-104257630-A | Polycationic nucleic acid compound nano-particles as well as preparation method and application thereof | UNIV SHANGHAI JIAOTONG | 2015-01-07 | — | — | CN | claimed |
| CN-104248771-A | NGF (Nerve Growth Factor) gene and PEI (Polyether Imide) derivative nano-particle compound and preparing method and application thereof | XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG U | 2014-12-31 | — | — | CN | claimed |
| US-20110006295-A1 | COMPOUNDS HAVING ELECTROLUMINESCENT OR ELECTRON TRANSPORT PROPERTIES | MERCK PATENT GMBH | 2011-01-13 | — | — | US | claimed |
| EP-2250151-A1 | COMPOUNDS HAVING ELECTROLUMINESCENT OR ELECTRON TRANSPORT PROPERTIES | Merck Patent GmbH (DE) | 2010-11-17 | — | — | EP | claimed |
| WO-2009112854-A1 | COMPOUNDS HAVING ELECTROLUMINESCENT OR ELECTRON TRANSPORT PROPERTIES | MERCK PATENT GMBH (DE) | 2009-09-17 | — | — | WO | claimed |
| US-20240309181-A1 | RUBBER COMPOSITION AND TIRE | BRIDGESTONE CORPORATION (JP) | 2024-09-19 | — | — | US | disclosed |
| US-4172937-A | REACTION OF A DIALDEHYDE AND DIAMINE IN A PHENOLIC COMPOUND | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1979-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110006295-A1 | COMPOUNDS HAVING ELECTROLUMINESCENT OR ELECTRON TRANSPORT PROPERTIES | NR2E3, NR4A2, NR4A3 | ALDH1A1 420/4885KDM4E 2623/4885PTGS2 2501/4885 |
| US-20180134643-A1 | SEPARATION OF ENANTIOMERS OF 3-ETHYLBICYCLO[3.2.0]HEPT-3-EN-6-ONE | ALDH7A1, OPRK1, SCN3A | ALDH1A1 14/4885KDM4E 2811/4885PTGS2 556/4885 |
| US-10150723-B2 | Separation of enantiomers of 3-ethylbicyclo[3.2.0]hept-3-en-6-one | ALDH7A1, OPRK1, SCN3A | ALDH1A1 14/4885KDM4E 2811/4885PTGS2 556/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.